Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy
Open Access
- 15 September 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (6), 2272
- https://doi.org/10.1182/blood-2002-06-1674
Abstract
Supported in part by Università di Bologna, Progetti di Ricerca ex-60% (M.C.).Keywords
This publication has 6 references indexed in Scilit:
- Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapyBlood, 2002
- Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapyBlood, 2001
- Thalidomide in the management of multiple myelomaSeminars in Hematology, 2001
- Thalidomide and dexamethasone combination for refractory multiple myelomaAnnals Of Oncology, 2001
- Deep Venous Thrombosis and Thalidomide Therapy for Multiple MyelomaNew England Journal of Medicine, 2001
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999